EFFECT OF MUSALI CHURNA IN SENSORY NEURAL HEARING LOSS - A RANDOMIZED CONTROLLED CLINICAL TRIA
Phase 1
- Conditions
- Health Condition 1: null- Hearing loss
- Registration Number
- CTRI/2018/07/014722
- Lead Sponsor
- Shri B M K Ayurveda Mahavidhalaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinical features of Bhadirya.
Mild to moderate hearing loss 26 to 40 db and 41 to 55 db
Age group 18 to 60 years
Irrespective of sex occupation
Controlled diabetic patient
Exclusion Criteria
Infective diseases like Encephalitis Herpes Mumps
Systemic disorders like uncontrolled DM HTN
Known case of aural tumours polyps etc
CSOM TM perforation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Musali Churna (Curculigo orchiodes) may prove as the promising economical treatment for sensory neural hearing loss <br/ ><br> <br/ ><br>Timepoint: 18 MONTHS
- Secondary Outcome Measures
Name Time Method Musali Churna (Curculigo orchiodes) may prove as the promising economical treatment for sensory neural hearing loss <br/ ><br> <br/ ><br>Timepoint: 45 days